Dopa‐responsive parkinsonism phenotype of spinocerebellar ataxia type 2
Identifieur interne : 006502 ( Main/Merge ); précédent : 006501; suivant : 006503Dopa‐responsive parkinsonism phenotype of spinocerebellar ataxia type 2
Auteurs : Chin-Song Lu [Taïwan] ; Yah-Huei Wu Chou [Taïwan] ; Tzu-Chen Yen [Taïwan] ; Chon-Haw Tsai [Taïwan] ; Rou-Shayn Chen [Taïwan] ; Hsiu-Chen Chang [Taïwan]Source :
- Movement Disorders [ 0885-3185 ] ; 2002-09.
English descriptors
- KwdEn :
- Aged, Atrophy (pathology), Cerebellum (pathology), Corpus Striatum (pathology), Corpus Striatum (physiopathology), Dopamine Agonists (therapeutic use), Genotype, Humans, Levodopa (therapeutic use), Magnetic Resonance Imaging, Male, Middle Aged, Organotechnetium Compounds (diagnostic use), Parkinsonian Disorders (drug therapy), Parkinsonian Disorders (genetics), Parkinsonian Disorders (pathology), Pedigree, Pons (pathology), Radiopharmaceuticals (diagnostic use), Spinocerebellar Ataxias (genetics), Spinocerebellar Ataxias (pathology), Spinocerebellar Ataxias (physiopathology), Substantia Nigra (pathology), Substantia Nigra (physiopathology), Tomography, Emission-Computed, Single-Photon, Tropanes (diagnostic use), [99mTc]TRODAT‐1 SPECT, ataxin‐2 gene, parkinsonism, spinocerebellar ataxia type 2.
- MESH :
- chemical , diagnostic use : Organotechnetium Compounds, Radiopharmaceuticals, Tropanes.
- chemical , therapeutic use : Dopamine Agonists, Levodopa.
- drug therapy : Parkinsonian Disorders.
- genetics : Parkinsonian Disorders, Spinocerebellar Ataxias.
- pathology : Atrophy, Cerebellum, Corpus Striatum, Parkinsonian Disorders, Pons, Spinocerebellar Ataxias, Substantia Nigra.
- physiopathology : Corpus Striatum, Spinocerebellar Ataxias, Substantia Nigra.
- Aged, Genotype, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Pedigree, Tomography, Emission-Computed, Single-Photon.
Abstract
We report on 2 brothers, Patients 1 and 2, who presented with a similar clinical syndrome consisting of resting tumor, bradykinesia, rigidity, and dysarthria at the ages of 40 and 43 years, respectively. An excellent response to levodopa therapy was observed throughout the disease course. No gait or limb ataxia, slow saccades, or decreased tendon reflexes were detected, but unsteadiness of gait with propulsion developed recently in Patient 1 approximately 25 years after disease onset. Magnetic resonance imaging demonstrated mild atrophy of the pons and cerebellum in Patient 1 and cerebellar atrophy in Patient 2. Expanded CAG repeats, numbering 36, in one allele of the ataxin‐2 gene were identified in Patient 1 only; his brother was not available for this investigation. With [99mTc]TRODAT‐1 single photon emission computed tomography of the brain, a significant bilateral and asymmetrical reduction of striatal dopamine transporters was found in Patient 1 compared to healthy controls. This bilateral reduction of striatal dopamine transporters resembled that observed in a set of controls with Parkinson's disease who had asymmetrical impairment. These results suggest that patients with familial parkinsonism who present with typical Parkinson's disease should be screened for the genetic defect of spinocerebellar ataxia type 2. The presynaptic impairment of nigrostriatal function is very likely to be the reason for levodopa responsiveness. © 2002 Movement Disorder Society
Url:
DOI: 10.1002/mds.10243
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000D00
- to stream Istex, to step Curation: 000D00
- to stream Istex, to step Checkpoint: 002D88
- to stream PubMed, to step Corpus: 003944
- to stream PubMed, to step Curation: 003944
- to stream PubMed, to step Checkpoint: 003B24
- to stream Ncbi, to step Merge: 000907
- to stream Ncbi, to step Curation: 000907
- to stream Ncbi, to step Checkpoint: 000907
Links to Exploration step
ISTEX:241E73A3889B0ED6D2494961E2F6056797CF272FLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dopa‐responsive parkinsonism phenotype of spinocerebellar ataxia type 2</title><author><name sortKey="Lu, Chin Ong" sort="Lu, Chin Ong" uniqKey="Lu C" first="Chin-Song" last="Lu">Chin-Song Lu</name></author><author><name sortKey="Wu Chou, Yah Uei" sort="Wu Chou, Yah Uei" uniqKey="Wu Chou Y" first="Yah-Huei" last="Wu Chou">Yah-Huei Wu Chou</name></author><author><name sortKey="Yen, Tzu Hen" sort="Yen, Tzu Hen" uniqKey="Yen T" first="Tzu-Chen" last="Yen">Tzu-Chen Yen</name></author><author><name sortKey="Tsai, Chon Aw" sort="Tsai, Chon Aw" uniqKey="Tsai C" first="Chon-Haw" last="Tsai">Chon-Haw Tsai</name></author><author><name sortKey="Chen, Rou Hayn" sort="Chen, Rou Hayn" uniqKey="Chen R" first="Rou-Shayn" last="Chen">Rou-Shayn Chen</name></author><author><name sortKey="Chang, Hsiu Hen" sort="Chang, Hsiu Hen" uniqKey="Chang H" first="Hsiu-Chen" last="Chang">Hsiu-Chen Chang</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:241E73A3889B0ED6D2494961E2F6056797CF272F</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1002/mds.10243</idno><idno type="url">https://api.istex.fr/document/241E73A3889B0ED6D2494961E2F6056797CF272F/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000D00</idno><idno type="wicri:Area/Istex/Curation">000D00</idno><idno type="wicri:Area/Istex/Checkpoint">002D88</idno><idno type="wicri:doubleKey">0885-3185:2002:Lu C:dopa:responsive:parkinsonism</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:12360557</idno><idno type="wicri:Area/PubMed/Corpus">003944</idno><idno type="wicri:Area/PubMed/Curation">003944</idno><idno type="wicri:Area/PubMed/Checkpoint">003B24</idno><idno type="wicri:Area/Ncbi/Merge">000907</idno><idno type="wicri:Area/Ncbi/Curation">000907</idno><idno type="wicri:Area/Ncbi/Checkpoint">000907</idno><idno type="wicri:doubleKey">0885-3185:2002:Lu C:dopa:responsive:parkinsonism</idno><idno type="wicri:Area/Main/Merge">006502</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Dopa‐responsive parkinsonism phenotype of spinocerebellar ataxia type 2</title><author><name sortKey="Lu, Chin Ong" sort="Lu, Chin Ong" uniqKey="Lu C" first="Chin-Song" last="Lu">Chin-Song Lu</name><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Neurology, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University</wicri:regionArea><wicri:noRegion>Chang Gung University</wicri:noRegion></affiliation></author><author><name sortKey="Wu Chou, Yah Uei" sort="Wu Chou, Yah Uei" uniqKey="Wu Chou Y" first="Yah-Huei" last="Wu Chou">Yah-Huei Wu Chou</name><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Human Molecular Genetics Laboratory, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University</wicri:regionArea><wicri:noRegion>Chang Gung University</wicri:noRegion></affiliation></author><author><name sortKey="Yen, Tzu Hen" sort="Yen, Tzu Hen" uniqKey="Yen T" first="Tzu-Chen" last="Yen">Tzu-Chen Yen</name><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Nuclear Medicine, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University</wicri:regionArea><wicri:noRegion>Chang Gung University</wicri:noRegion></affiliation></author><author><name sortKey="Tsai, Chon Aw" sort="Tsai, Chon Aw" uniqKey="Tsai C" first="Chon-Haw" last="Tsai">Chon-Haw Tsai</name><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Neurology, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University</wicri:regionArea><wicri:noRegion>Chang Gung University</wicri:noRegion></affiliation></author><author><name sortKey="Chen, Rou Hayn" sort="Chen, Rou Hayn" uniqKey="Chen R" first="Rou-Shayn" last="Chen">Rou-Shayn Chen</name><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Neurology, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University</wicri:regionArea><wicri:noRegion>Chang Gung University</wicri:noRegion></affiliation></author><author><name sortKey="Chang, Hsiu Hen" sort="Chang, Hsiu Hen" uniqKey="Chang H" first="Hsiu-Chen" last="Chang">Hsiu-Chen Chang</name><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Neurology, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University</wicri:regionArea><wicri:noRegion>Chang Gung University</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>New York</pubPlace><date type="published" when="2002-09">2002-09</date><biblScope unit="vol">17</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="1046">1046</biblScope><biblScope unit="page" to="1051">1051</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">241E73A3889B0ED6D2494961E2F6056797CF272F</idno><idno type="DOI">10.1002/mds.10243</idno><idno type="ArticleID">MDS10243</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Atrophy (pathology)</term><term>Cerebellum (pathology)</term><term>Corpus Striatum (pathology)</term><term>Corpus Striatum (physiopathology)</term><term>Dopamine Agonists (therapeutic use)</term><term>Genotype</term><term>Humans</term><term>Levodopa (therapeutic use)</term><term>Magnetic Resonance Imaging</term><term>Male</term><term>Middle Aged</term><term>Organotechnetium Compounds (diagnostic use)</term><term>Parkinsonian Disorders (drug therapy)</term><term>Parkinsonian Disorders (genetics)</term><term>Parkinsonian Disorders (pathology)</term><term>Pedigree</term><term>Pons (pathology)</term><term>Radiopharmaceuticals (diagnostic use)</term><term>Spinocerebellar Ataxias (genetics)</term><term>Spinocerebellar Ataxias (pathology)</term><term>Spinocerebellar Ataxias (physiopathology)</term><term>Substantia Nigra (pathology)</term><term>Substantia Nigra (physiopathology)</term><term>Tomography, Emission-Computed, Single-Photon</term><term>Tropanes (diagnostic use)</term><term>[99mTc]TRODAT‐1 SPECT</term><term>ataxin‐2 gene</term><term>parkinsonism</term><term>spinocerebellar ataxia type 2</term></keywords><keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>Organotechnetium Compounds</term><term>Radiopharmaceuticals</term><term>Tropanes</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Dopamine Agonists</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinsonian Disorders</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Parkinsonian Disorders</term><term>Spinocerebellar Ataxias</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Atrophy</term><term>Cerebellum</term><term>Corpus Striatum</term><term>Parkinsonian Disorders</term><term>Pons</term><term>Spinocerebellar Ataxias</term><term>Substantia Nigra</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Corpus Striatum</term><term>Spinocerebellar Ataxias</term><term>Substantia Nigra</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Genotype</term><term>Humans</term><term>Magnetic Resonance Imaging</term><term>Male</term><term>Middle Aged</term><term>Pedigree</term><term>Tomography, Emission-Computed, Single-Photon</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We report on 2 brothers, Patients 1 and 2, who presented with a similar clinical syndrome consisting of resting tumor, bradykinesia, rigidity, and dysarthria at the ages of 40 and 43 years, respectively. An excellent response to levodopa therapy was observed throughout the disease course. No gait or limb ataxia, slow saccades, or decreased tendon reflexes were detected, but unsteadiness of gait with propulsion developed recently in Patient 1 approximately 25 years after disease onset. Magnetic resonance imaging demonstrated mild atrophy of the pons and cerebellum in Patient 1 and cerebellar atrophy in Patient 2. Expanded CAG repeats, numbering 36, in one allele of the ataxin‐2 gene were identified in Patient 1 only; his brother was not available for this investigation. With [99mTc]TRODAT‐1 single photon emission computed tomography of the brain, a significant bilateral and asymmetrical reduction of striatal dopamine transporters was found in Patient 1 compared to healthy controls. This bilateral reduction of striatal dopamine transporters resembled that observed in a set of controls with Parkinson's disease who had asymmetrical impairment. These results suggest that patients with familial parkinsonism who present with typical Parkinson's disease should be screened for the genetic defect of spinocerebellar ataxia type 2. The presynaptic impairment of nigrostriatal function is very likely to be the reason for levodopa responsiveness. © 2002 Movement Disorder Society</div></front></TEI><double doi="10.1002/mds.10243"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dopa‐responsive parkinsonism phenotype of spinocerebellar ataxia type 2</title><author><name sortKey="Lu, Chin Ong" sort="Lu, Chin Ong" uniqKey="Lu C" first="Chin-Song" last="Lu">Chin-Song Lu</name></author><author><name sortKey="Wu Chou, Yah Uei" sort="Wu Chou, Yah Uei" uniqKey="Wu Chou Y" first="Yah-Huei" last="Wu Chou">Yah-Huei Wu Chou</name></author><author><name sortKey="Yen, Tzu Hen" sort="Yen, Tzu Hen" uniqKey="Yen T" first="Tzu-Chen" last="Yen">Tzu-Chen Yen</name></author><author><name sortKey="Tsai, Chon Aw" sort="Tsai, Chon Aw" uniqKey="Tsai C" first="Chon-Haw" last="Tsai">Chon-Haw Tsai</name></author><author><name sortKey="Chen, Rou Hayn" sort="Chen, Rou Hayn" uniqKey="Chen R" first="Rou-Shayn" last="Chen">Rou-Shayn Chen</name></author><author><name sortKey="Chang, Hsiu Hen" sort="Chang, Hsiu Hen" uniqKey="Chang H" first="Hsiu-Chen" last="Chang">Hsiu-Chen Chang</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:241E73A3889B0ED6D2494961E2F6056797CF272F</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1002/mds.10243</idno><idno type="url">https://api.istex.fr/document/241E73A3889B0ED6D2494961E2F6056797CF272F/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000D00</idno><idno type="wicri:Area/Istex/Curation">000D00</idno><idno type="wicri:Area/Istex/Checkpoint">002D88</idno><idno type="wicri:doubleKey">0885-3185:2002:Lu C:dopa:responsive:parkinsonism</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Dopa‐responsive parkinsonism phenotype of spinocerebellar ataxia type 2</title><author><name sortKey="Lu, Chin Ong" sort="Lu, Chin Ong" uniqKey="Lu C" first="Chin-Song" last="Lu">Chin-Song Lu</name><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Neurology, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University</wicri:regionArea><wicri:noRegion>Chang Gung University</wicri:noRegion></affiliation></author><author><name sortKey="Wu Chou, Yah Uei" sort="Wu Chou, Yah Uei" uniqKey="Wu Chou Y" first="Yah-Huei" last="Wu Chou">Yah-Huei Wu Chou</name><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Human Molecular Genetics Laboratory, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University</wicri:regionArea><wicri:noRegion>Chang Gung University</wicri:noRegion></affiliation></author><author><name sortKey="Yen, Tzu Hen" sort="Yen, Tzu Hen" uniqKey="Yen T" first="Tzu-Chen" last="Yen">Tzu-Chen Yen</name><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Nuclear Medicine, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University</wicri:regionArea><wicri:noRegion>Chang Gung University</wicri:noRegion></affiliation></author><author><name sortKey="Tsai, Chon Aw" sort="Tsai, Chon Aw" uniqKey="Tsai C" first="Chon-Haw" last="Tsai">Chon-Haw Tsai</name><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Neurology, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University</wicri:regionArea><wicri:noRegion>Chang Gung University</wicri:noRegion></affiliation></author><author><name sortKey="Chen, Rou Hayn" sort="Chen, Rou Hayn" uniqKey="Chen R" first="Rou-Shayn" last="Chen">Rou-Shayn Chen</name><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Neurology, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University</wicri:regionArea><wicri:noRegion>Chang Gung University</wicri:noRegion></affiliation></author><author><name sortKey="Chang, Hsiu Hen" sort="Chang, Hsiu Hen" uniqKey="Chang H" first="Hsiu-Chen" last="Chang">Hsiu-Chen Chang</name><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Neurology, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University</wicri:regionArea><wicri:noRegion>Chang Gung University</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>New York</pubPlace><date type="published" when="2002-09">2002-09</date><biblScope unit="vol">17</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="1046">1046</biblScope><biblScope unit="page" to="1051">1051</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">241E73A3889B0ED6D2494961E2F6056797CF272F</idno><idno type="DOI">10.1002/mds.10243</idno><idno type="ArticleID">MDS10243</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>[99mTc]TRODAT‐1 SPECT</term><term>ataxin‐2 gene</term><term>parkinsonism</term><term>spinocerebellar ataxia type 2</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We report on 2 brothers, Patients 1 and 2, who presented with a similar clinical syndrome consisting of resting tumor, bradykinesia, rigidity, and dysarthria at the ages of 40 and 43 years, respectively. An excellent response to levodopa therapy was observed throughout the disease course. No gait or limb ataxia, slow saccades, or decreased tendon reflexes were detected, but unsteadiness of gait with propulsion developed recently in Patient 1 approximately 25 years after disease onset. Magnetic resonance imaging demonstrated mild atrophy of the pons and cerebellum in Patient 1 and cerebellar atrophy in Patient 2. Expanded CAG repeats, numbering 36, in one allele of the ataxin‐2 gene were identified in Patient 1 only; his brother was not available for this investigation. With [99mTc]TRODAT‐1 single photon emission computed tomography of the brain, a significant bilateral and asymmetrical reduction of striatal dopamine transporters was found in Patient 1 compared to healthy controls. This bilateral reduction of striatal dopamine transporters resembled that observed in a set of controls with Parkinson's disease who had asymmetrical impairment. These results suggest that patients with familial parkinsonism who present with typical Parkinson's disease should be screened for the genetic defect of spinocerebellar ataxia type 2. The presynaptic impairment of nigrostriatal function is very likely to be the reason for levodopa responsiveness. © 2002 Movement Disorder Society</div></front></TEI></ISTEX><PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2.</title><author><name sortKey="Lu, Chin Song" sort="Lu, Chin Song" uniqKey="Lu C" first="Chin-Song" last="Lu">Chin-Song Lu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University, Taiwan. c81214@adm.cgmh.org.tw</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Neurology, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University</wicri:regionArea><wicri:noRegion>Chang Gung University</wicri:noRegion></affiliation></author><author><name sortKey="Wu Chou, Yah Huei" sort="Wu Chou, Yah Huei" uniqKey="Wu Chou Y" first="Yah-Huei" last="Wu Chou">Yah-Huei Wu Chou</name></author><author><name sortKey="Yen, Tzu Chen" sort="Yen, Tzu Chen" uniqKey="Yen T" first="Tzu-Chen" last="Yen">Tzu-Chen Yen</name></author><author><name sortKey="Tsai, Chon Haw" sort="Tsai, Chon Haw" uniqKey="Tsai C" first="Chon-Haw" last="Tsai">Chon-Haw Tsai</name></author><author><name sortKey="Chen, Rou Shayn" sort="Chen, Rou Shayn" uniqKey="Chen R" first="Rou-Shayn" last="Chen">Rou-Shayn Chen</name></author><author><name sortKey="Chang, Hsiu Chen" sort="Chang, Hsiu Chen" uniqKey="Chang H" first="Hsiu-Chen" last="Chang">Hsiu-Chen Chang</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2002">2002</date><idno type="RBID">pubmed:12360557</idno><idno type="pmid">12360557</idno><idno type="doi">10.1002/mds.10243</idno><idno type="wicri:Area/PubMed/Corpus">003944</idno><idno type="wicri:Area/PubMed/Curation">003944</idno><idno type="wicri:Area/PubMed/Checkpoint">003B24</idno><idno type="wicri:Area/Ncbi/Merge">000907</idno><idno type="wicri:Area/Ncbi/Curation">000907</idno><idno type="wicri:Area/Ncbi/Checkpoint">000907</idno><idno type="wicri:doubleKey">0885-3185:2002:Lu C:dopa:responsive:parkinsonism</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2.</title><author><name sortKey="Lu, Chin Song" sort="Lu, Chin Song" uniqKey="Lu C" first="Chin-Song" last="Lu">Chin-Song Lu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University, Taiwan. c81214@adm.cgmh.org.tw</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Neurology, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University</wicri:regionArea><wicri:noRegion>Chang Gung University</wicri:noRegion></affiliation></author><author><name sortKey="Wu Chou, Yah Huei" sort="Wu Chou, Yah Huei" uniqKey="Wu Chou Y" first="Yah-Huei" last="Wu Chou">Yah-Huei Wu Chou</name></author><author><name sortKey="Yen, Tzu Chen" sort="Yen, Tzu Chen" uniqKey="Yen T" first="Tzu-Chen" last="Yen">Tzu-Chen Yen</name></author><author><name sortKey="Tsai, Chon Haw" sort="Tsai, Chon Haw" uniqKey="Tsai C" first="Chon-Haw" last="Tsai">Chon-Haw Tsai</name></author><author><name sortKey="Chen, Rou Shayn" sort="Chen, Rou Shayn" uniqKey="Chen R" first="Rou-Shayn" last="Chen">Rou-Shayn Chen</name></author><author><name sortKey="Chang, Hsiu Chen" sort="Chang, Hsiu Chen" uniqKey="Chang H" first="Hsiu-Chen" last="Chang">Hsiu-Chen Chang</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><imprint><date when="2002" type="published">2002</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Atrophy (pathology)</term><term>Cerebellum (pathology)</term><term>Corpus Striatum (pathology)</term><term>Corpus Striatum (physiopathology)</term><term>Dopamine Agonists (therapeutic use)</term><term>Genotype</term><term>Humans</term><term>Levodopa (therapeutic use)</term><term>Magnetic Resonance Imaging</term><term>Male</term><term>Middle Aged</term><term>Organotechnetium Compounds (diagnostic use)</term><term>Parkinsonian Disorders (drug therapy)</term><term>Parkinsonian Disorders (genetics)</term><term>Parkinsonian Disorders (pathology)</term><term>Pedigree</term><term>Pons (pathology)</term><term>Radiopharmaceuticals (diagnostic use)</term><term>Spinocerebellar Ataxias (genetics)</term><term>Spinocerebellar Ataxias (pathology)</term><term>Spinocerebellar Ataxias (physiopathology)</term><term>Substantia Nigra (pathology)</term><term>Substantia Nigra (physiopathology)</term><term>Tomography, Emission-Computed, Single-Photon</term><term>Tropanes (diagnostic use)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>Organotechnetium Compounds</term><term>Radiopharmaceuticals</term><term>Tropanes</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Dopamine Agonists</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinsonian Disorders</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Parkinsonian Disorders</term><term>Spinocerebellar Ataxias</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Atrophy</term><term>Cerebellum</term><term>Corpus Striatum</term><term>Parkinsonian Disorders</term><term>Pons</term><term>Spinocerebellar Ataxias</term><term>Substantia Nigra</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Corpus Striatum</term><term>Spinocerebellar Ataxias</term><term>Substantia Nigra</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Genotype</term><term>Humans</term><term>Magnetic Resonance Imaging</term><term>Male</term><term>Middle Aged</term><term>Pedigree</term><term>Tomography, Emission-Computed, Single-Photon</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We report on 2 brothers, Patients 1 and 2, who presented with a similar clinical syndrome consisting of resting tumor, bradykinesia, rigidity, and dysarthria at the ages of 40 and 43 years, respectively. An excellent response to levodopa therapy was observed throughout the disease course. No gait or limb ataxia, slow saccades, or decreased tendon reflexes were detected, but unsteadiness of gait with propulsion developed recently in Patient 1 approximately 25 years after disease onset. Magnetic resonance imaging demonstrated mild atrophy of the pons and cerebellum in Patient 1 and cerebellar atrophy in Patient 2. Expanded CAG repeats, numbering 36, in one allele of the ataxin-2 gene were identified in Patient 1 only; his brother was not available for this investigation. With [(99m)Tc]TRODAT-1 single photon emission computed tomography of the brain, a significant bilateral and asymmetrical reduction of striatal dopamine transporters was found in Patient 1 compared to healthy controls. This bilateral reduction of striatal dopamine transporters resembled that observed in a set of controls with Parkinson's disease who had asymmetrical impairment. These results suggest that patients with familial parkinsonism who present with typical Parkinson's disease should be screened for the genetic defect of spinocerebellar ataxia type 2. The presynaptic impairment of nigrostriatal function is very likely to be the reason for levodopa responsiveness.</div></front></TEI></PubMed></double></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006502 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 006502 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Merge
|type= RBID
|clé= ISTEX:241E73A3889B0ED6D2494961E2F6056797CF272F
|texte= Dopa‐responsive parkinsonism phenotype of spinocerebellar ataxia type 2
}}
| This area was generated with Dilib version V0.6.23. |  |